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Abstract 
Hypoxia-induced hepatocyte injury results not only from ATP depletion but also from reductive stress and oxygen activation. Thus the 
NADH/NAD + ratio was markedly increased in isolated hepatocytes maintained under 95% N2/5% CO 2 in Krebs-Henseleit buffer well 
before plasma membrane disruption occurred. Glycolytic nutrients fructose, dihydroxyacetone or glyceraldehyde prevented cytotoxicity, 
restored the NADH/NAD + ratio, and prevented complete ATP depletion. However, the NADH generating nutrients orbitol, xylitol, 
glycerol and fl-hydroxybutyrate enhanced hypoxic cytotoxicity even though ATP depletion was not affected. On the other hand, NADH 
oxidising metabolic intermediates oxaloacetate or acetoacetate prevented hypoxic ytotoxicity but did not affect ATP depletion. Restoring 
the cellular NADH/NAD ÷ ratio with the artificial electron acceptors dichlorophenolindophenol andMethylene blue also prevented 
hypoxic injury and partly restored ATP levels. Ethanol which further increased the cellular NADH/NAD ÷ ratio increased by hypoxia 
also markedly increased toxicity whereas acetaldehyde which restored the normal cellular NADH/NAD + ratio, prevented toxicity even 
though hypoxia induced ATP depletion was little affected by ethanol or acetaldehyde. The viability of hypoxic hepatocytes is therefore 
more dependent on the maintenance of normal redox homeostasis than ATP levels. GSH may buffer these redox changes as hypoxia 
caused cell injury much sooner with GSH depleted hepatocytes. Hypoxia also caused an intracellular release of free iron and cytotoxicity 
was prevented by desferoxamine. Furthermore, increasing the cellular NADH/NAD ÷ ratio markedly increased the intracellular release of 
iron. Hypoxia-induced hepatocyte injury was also prevented by oxypurinol, a xanthine oxidase inhibitor. Polyphenolic antioxidants or the 
superoxide dismutase mimic, TEMPO partly prevented cytotoxicity suggesting that reactive oxygen species contributed to the 
cytotoxicity. The above results suggests that hypoxia induced hepatocyte injury results from sustained reductive stress and oxygen 
activation. 
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1. Int roduct ion 
Hypoxia resulting from lhe impairment of tissue oxygen 
delivery - -  e.g., as a result of ischemia I is a primary 
cause of cell injury. Other examples of hypoxic injury 
include patients with severe pulmonary insufficiency and 
consequent hypoxemia. In these patients, serum levels of 
hepatic enzymes may increase and ultrastructural changes 
appear in the centrilobular liver cells [1] probably because 
the centrilobular zone of the hepatic acinus has the lowest 
Abbreviations: DCPIP, dichlorophenolindophenol; DETAPAC, dieth- 
ylenetriaminepentaacetic acid; DMSO, dimethylsulfoxide; EGTA, ethy- 
lene glycol bis(fl-aminoethyl etlher)-N,N,N'N'-tetraacetic acid; Hepes, 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; MB, Methylene blue; 
MeP, methyl pyrazole; ROS, reactive oxygen species. 
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oxygen concentration. Liver injury in the isolated perfused 
rat liver following hypoxia also predominates in the cen- 
trilobular zone [2]. Liver injury in alcoholics also starts and 
predominates in the centrilobular zone [3]. 
Several biochemical changes have been found preced- 
ing cell injury induced by hypoxia that probably arise from 
the inactivation of oxidative phosphorylation i the elec- 
tron-transport system. These include ATP depletion [4], 
increased cytosolic calcium [5] and sodium [6], phospho- 
lipase A2 activation, and membrane phospholipid egrada- 
tion [7]. A marked increase in the lactate/pyruvate ratio an 
indicator of the free cytoplasmic NADH/NAD ÷ ratio 
[8,9] also occurs in hypoxic hepatocytes [10]. It has also 
been proposed that an increase in the blood-ketone body 
ratio (acetoacetic/f l -hydroxybutyric acid), an indicator of 
the mitochondrial NADH/NAD + ratio and redox potential 
should be used as an early indicator of hepatic failure [11]. 
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In the present study, we have correlated cytotoxicity, 
ATP levels and the lactate/pyruvate ratio of hepatocyte 
injured by hypoxia. The susceptibility of hepatocytes to
hypoxic cytotoxicity increased if the hepatocyte mitochon- 
drial or cytoplasmic redox state was made more reduced 
by adding NADH generating lycolytic metabolites, or 
ethanol. In contrast, hepatocytes were more resistant o 
hypoxic injury if the cellular redox state was made more 
oxidised with NADH utilising intermediary metabolites or 
artificial electron acceptors. An increase in reductive stress 
released intracellular i on and reductively activated oxy- 
gen. Cytotoxicity, however, did not correlate with ATP 
levels thereby showing for the first time that prolonged 
reductive stress resulting in oxygen activation and not 
ATP depletion is responsible for hypoxic injury. 
2. Materials and methods 
2.1. Materials 
Alanine, acetoacetic acid, dihydroxyacetone, dichloro- 
phenolindophenol (DCPIP), EGTA, fluoro-2,4-dinitro- 
benzene, fructose, glutathione, DL-glyceraldehyde, glu- 
tamine, /3-hydroxybutyrate, iodoacetic acid, lactic acid, 
Methylene blue, methyl pyrazole, monensin, pyruvic acid, 
sorbitol, Trypan blue, and xylitol were purchased from 
Sigma (St. Louis, MO). Collagenase (from Clostridium 
histolyticum), Hepes, and bovine serum albumin were 
obtained from Boehringer-Mannheim (Montreal, PQ). 
HPLC grade solvents were purchased from Calden (Geo- 
rgetown, Ont.). Desferoxamine was a gift from Ciba-Geigy 
(Canada). All other chemicals used were of analytical 
grade. 
2.2. Isolation and incubation of hepatocytes 
Freshly isolated hepatocytes were prepared from adult 
male Sprague-Dawley rats (280-300 g) fed ad libitum. 
The cells were isolated by collagenase perfusion of the 
liver as described by Moldeus et al. [12]. The cells (1 • 10 6 
cells/ml) were preincubated in Krebs-Henseleit bicarbon- 
ate buffer (pH 7.4) supplemented with 12.5 mM Hepes for 
30 min in an atmosphere of 10% 02/5% CO2/85% N 2 in 
continuously rotating 50 ml round bottom flasks before the 
addition of chemicals. For experiments performed under 
hypoxic conditions, the cells were incubated under an 
atmosphere of 5% CO2/95% N 2 following a 30 min 
preincubation period under aerobic conditions. Oxygen 
electrode measurement showed that the oxygen concentra- 
tion in the cellular medium was < 0.01% (1.0-1.5 /zM) 
40 min after the hepatocytes were added to the flasks 
under the N 2 atmosphere. Glutathione depleted hepato- 
cytes were obtained as previously described [13]. Stock 
solutions of chemicals and nutrients were made either in 
incubation buffer or in DMSO and added to the hepatocyte 
suspensions at the indicated time points. 
2.3. Measurement of cytotoxicity 
The viability of the hepatocytes were assessed by Try- 
pan blue uptake. Viability was examined immediately after 
isolation, and during the incubation at various time points. 
2.4. Glutathione assay 
The total amount of GSH in isolated hepatocytes was 
measured in deproteinised samples (5% meta phosphoric 
acid) after derivatization with iodoacetic acid and fluoro- 
2,4-dinitrobenzene by HPLC as described by Reed et al. 
[14]. 
2.5. Determination of intracellular ATP 
Intracellular ATP in hepatocytes was extracted using an 
alkaline extraction procedure and quantified by HPLC, 
using C18 # Bondapak reverse-phase column (Waters, 
Milford) as described by Stocchi et al. [15]. 
Table 1 
Modulation of hypoxic cytotoxicity in hepatocytes by glycolytic intermediates 
Nutrient (10 mM) % Trypan blue uptake Lactate/pyruvate ratio 
60 min 120 min 180 min 60 min 120min 
None 33___4 51+6 82+7 38 47 
Fructose 22 _+ 3 24 _+ 3 27 + 4 * 14 15 
+ monensin (10/xM) 24 _+ 3 27 + 4 32 + 4 * 18 19 
Monensin (10/xM) 45 _+ 5 79 _+ 5 100 51 64 
Dihydroxyacetone 27 _+ 4 31 -t- 3 36 + 4 * 8 9 
DL-Glyceraldehyde 21 ___ 3 23 + 4 30 + 4 * 11 9 
Hepatocytes (106 cel ls/ml) were incubated in Krebs-Henseleit buffer (pH 7.4) at 37°C. Cells were maintained under hypoxic environment asdescribed in 
Section 2. Cell viability was determined as the percentage of cells taking up Trypan blue. Values are expressed as means of the three separate xperiments 
( _  S.D.). 
* Significant difference in comparison with aerobic ontrol (p  < 0.001). 
Lactate and pyruvate were determined using lactate dehydrogenase and values are expressed as mean from three separate xperiments. 
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2.6. Measurement of  lactate and pyruvate 
Lactic acid and pyruvic acid were determined with 
lactate dehydrogenase by following the reduction or oxida- 
tion of NADH respectively at 340 nm as described previ- 
ously [16,17]. 
2.7. Iron release assay 
Free iron (Fe e+) in hepatocytes was determined by 
bathophenanthroline disulfonate (BPS) assay as described 
[18]. Aliquots were taken at different ime points and were 
filtered through 0.45 /~m membrane filters after addition 
of 0.3% digitonin to render the plasma membrane perme- 
able. BPS (1 mM) was added to 1 ml of filtrate and the 
absorbance was measured at 537 nm. 
2.8. Statistics 
Statistically significant differences between control and 
experimental groups were obtained using Student t-test. 
The minimal level of significance chosen was p < 0.05. 
3. Results  
3.1. Effect of  hypoxia on cytosolic NADH/NAD ÷ and 
cellular ATP levels 
The hepatocyte lactate/pyruvate ratio, reflecting cy- 
tosolic NADH/NAD ÷ ratiio was markedly increased in 
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Fig. 1. Hypoxia induced cytotoxicity in isolated rat hepatocytes. Hypoxic 
cytotoxicity is enhanced by intracellular GSH depletion. Cell viability 
was determined byTrypan blue uptake at various time points. Key: (×) 
control, (O) hypoxia, and (0) hypoxia + GSH depletion. * Significant 
difference from aerobic ontrol (p < 0.001). * * Significant difference 
from hypoxic ontrol (p < 0.001). 
30 '  
A2sl 
m 
i 0-  
5 -  
0 - i • i - i - i 
0 30 60 90 120 
Time (rain) 
30 
0 i • i • i . i • m 
30  60  90  120  
Time (mini 
• i • i • i - i 
30  60  90  120 
Time (rain) 
Fig. 2. Hypoxia induced ATP depletion (A) Modulation by various 
glycolytic nutrients. Key: (x) no addition, (0) fructose, (O) dihydroxy- 
acetone, ( [] ) nL-glyceraldehyde, ( • ) alanine, and ( A ) glutamine. (B) 
Modulation by NADH generating utrients. Key: (X) no addition, (O) 
sorbitol, ([] ) xylitol, ( • ) glycerol, ( A ) ethanol, and ( • ) /3-hydroxy- 
butyrate. (C) Modulation by NADH oxidising agents. Key: (×) no 
addition, (O) DCPIP, (0) MB, ([]) acetaldehyde, (•)  acetoacetate, and 
(zx) oxaloacetate. ATP levels in aerobic ontrol hepatocytes was (40+ 5 
nmol/106 cells). * Significant difference from control (p < 0.001). 
hepatocytes maintained under hypoxia (95% N2/5% CO 2) 
(Table 1) indicating that the cell became more reduced. 
The increased pyruvate levels could be attributed to a 
decrease in the rate of pyruvate oxidation by the tricar- 
boxylic acid cycle. This increase in NADH/NAD + ratio 
accompanied a depletion of ATP (50% in 60 min) and 
preceded cytotoxicity (50% occurring at about 2 h, Figs. 1 
and 2). Glutathione depleted hepatocytes were much more 
susceptible to hypoxic cell injury (50% cytotoxicity occur- 
ring in about 1 hour, Fig. 1). 
3.2. Effect of nutrients on NADH / NAD +, ATP levels and 
cytotoxocity 
As shown in Fig. 2A and Table 1, the glycolytic 
nutrients fructose, dihydroxyacetone, and glyceraldehyde, 
prevented cytotoxicity, the increase in lactate/pyruvate 
ratio and ATP depletion (90% at 1 hour and 40% at 2 
hour). Monensin, a H+/Na ÷ ionophore did not affect the 
cytoprotective action of fructose (Table 1) suggesting that 
the protective ffect of fructose resulted from restoring the 
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Table 3 
Hypoxic cytotoxicity in hepatocytes i increased by increasing cellular 
reductive stress or by restoring redox homeostasis 
Nutrient (10 raM) % Trypan blue uptake at time (min) 
60 120 180 
None 35_+4 54_+6 83_+8 
Increase cytosolic NADH 
Sorbitol 46 _+ 5 75 _+ 7 100 * 
Xylitol 49 _+ 6 78 _+ 8 100 ~ 
Glycerol 43 _+ 4 71 _+ 6 100 * 
Increase mitochondrial NADH 
/3-Hydroxybutyrate 41 _+ 4 70 _+ 6 100 * 
Alanine 31 _+ 4 62 _+ 6 100 * 
Glutamine (5 mM) 34 + 3 67 +4 100 * 
Oxidise NADH 
Oxaloacetate 22 _+ 3 31 _+ 4 34 _+ 6 * 
Acetoacetate 25 _+ 3 36 _+ 4 43 _+ 5 t 
Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer 
(pH 7.4) at 37°C. Cells were maintained under hypoxic environment as 
described in Section 2. Cell viability was determined as the percentage of
cells taking up Trypan blue. Values are expressed as means of the three 
separate xperiments ( + S.D.). 
* Significantly increased in comparison with hypoxic control ( p < 0.001). 
+ Significantly decreased in comparison with hypoxic control (p  < 
0.001). 
prevent ATP depletion. However, hypoxic cell injury was 
prevented by oxaloacetate or acetoacetate which oxidised 
mitochondrial NADH and decreased the lactate/pyruvate 
ratio (Tables 2 and 3) but did not restore ATP levels (Fig. 
2C). This further indicates that cytotoxicity correlated 
more with the degree of reductive stress than with the 
extent of ATP depletion. Thus, intermediary metabolites 
which prevented hypoxia induced reductive stress also 
prevented hypoxic injury. 
3.3. Protection by artificial electron acceptors 
Further evidence that hypoxic cell viability depends on 
the maintenance of normal redox homeostasis is that addi- 
tion of the artificial electron acceptors, DCPIP and Methy- 
lene blue decreased the lactate/pyruvate ratio (Table 2) 
and prevented hypoxic toxicity (Table 4). However, ATP 
depletion was also partly prevented by these electron 
acceptors (Fig. 2C). 
3.4. Effect of ethanol and acetaldehyde on NADH / NAD +, 
ATP and cytotoxicity 
normal redox state (lactate/pyruvate ratio) rather than 
causing acidosis as a result of glycolysis. Furthermore, the 
NADH generating glycolytic nutrients xylitol, sorbitol and 
glycerol increased both hepatocyte lactate/pyruvate ratio 
(Table 2) and hypoxic injury without restoring ATP levels 
(Fig. 2B, Table 3) indicating that cytotoxicity correlated 
with the degree of reductive stress but not ATP depletion. 
fl-Hydroxybutyrate, a ketoacid nutrient which reduces 
mitochondrial NAD + also increased the lactate/pyruvate 
ratio and also increased hypoxic cell injury but did not 
Hypoxic cell injury was markedly increased by ethanol 
(Table 5). These effects on hypoxic injury did not correlate 
with ATP depletion as ethanol did not affect ATP deple- 
tion (Fig. 2C). However, ethanol further increased the 
lactate/pyruvate ratio increased by hypoxia indicating that 
the reductive stress induced by hypoxia was further in- 
creased by ethanol (Table 2). Decreased pyruvate levels 
were mainly responsible for the ethanol-induced increase 
in lactate/pyruvate ratio. Hypoxic cell injury was not 
increased by ethanol in the presence of the alcohol dehy- 
drogenase inhibitor methyl pyrazole. Inactivation of alco- 
Table 2 
Modulation of cytosolic redox state (lactate/pyruvate) of isolated rat hepatocytes under hypoxia 
Addition 6 Lactate (nmol/10 cells) Pyruvate (nmol/10 6 cells) Lactate/pyruvate ratio 
60min 120min 60 min 120min 60min 120 min 
None 630 647 18 14 35 46 
Sorbitol (10 mM) 474 557 9 8 53 70 
Xylitol (10 mM) 461 514 7 4 66 128 
Glycerol (10 mM) 468 533 8 6 59 89 
fl-OHButyrate (10 mM) 612 630 11 8 56 79 
Alanine (10 mM) 768 901 17 20 46 88 
Glutamine (5 mM) 767 781 15 13 51 61 
Oxaloacetate (10 mM) 1058 1993 158 153 7 13 
Acetoacetate (10 mM) 819 946 68 73 12 13 
DCPIP (0.08 mM) 830 852 27 32 31 27 
MB (0.085 mM) 851 873 28 35 30 25 
Ethanol (40 mM) 412 406 5 4 82 102 
+MeP (0.1 mM) 573 605 13 12 44 50 
Acetaldehyde (5 mM) 654 815 19 22 34 37 
+MeP (0.1 mM) 631 754 17 6 37 126 
Aerobic 100 111 14 14 7 8 
Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer (pH 7.4) at 37°C. Cells were maintained under hypoxic environment as described in 
Section 2. Lactate and pyruvate were determined using lactate dehydrogenase and values are expressed as mean from three separate xperiments. 
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Table 4 
Oxidative stress induced by artificial electron acceptors dichlorophenol 
indophenol (DCPIP) and Methylene blue (MB) prevent hypoxic ytotoxi- 
city 
% Trypml blue uptake at time (min) 
Addition 60 120 180 
HYPOXIC 
None 36-+4 51 -+6 86_+8 
DCPIP (80/zM) 33 _+ 3 36 + 4 44-+ 5 * 
MB (85/zM) 31 -+3 38+4 47_+5 * 
AEROBIC 
None 22 _+ 2 23 _+ 3 25 + 3 
DCPIP (80/xM) 34_+4 54+6 100 * 
MB (85 g.M) 36_+4 51 +6 85-t-9 * 
Hepatocytes (10 6 cells/ml) were incubated in Krebs-Henseleit buffer 
(pH 7.4) at 37°C. Cells were maintained under hypoxic environment as 
described in Section 2. Cell viability was determined asthe percentage of
cells taking up Trypan blue. Values are expressed as means of the three 
separate experiments ( + S.D.). 
* Significant difference from hypoxic ontrol (p < 0.001). 
+ Significant difference from hypoxic ontrol (p < 0.001). 
hol dehydrogenase in hepatocytes also prevented the 
ethanol induced increase in lactate/pyruvate ratio. These 
results on hypoxic injury therefore correlate with effects 
on redox homeostasis rather than ATP levels. 
Hypoxic cell injury was prevented by acetaldehyde 
(Table 5) and acetaldehyde only partly prevented ATP 
depletion (Fig. 2C). However, acetaldehyde markedly de- 
creased the lactate/pyruvate ratio. By contrast, hypoxic 
cell injury in alcohol dehydrogenase inactivated hepato- 
cytes was increased by acetaldehyde as was the 
lactate/pyruvate ratio (Table 2) and could be attributed to 
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Fig. 3. Increase in intracellular Fe 2+ under hypoxia. Aliquots were taken 
at 45 and 90 min and Fe 2+ was measured as described in Section 2. 
Values are expressed as mean-+ SD of three separate xperiments. Bars 
from left to fight indicate, respectively: hypoxia; +ethanol (20 raM); 
+ xylitol (10 raM); + sorbitol (10 raM); + dihydroxyacetone (10 raM), 
and + desferoxamine (1 raM). 
mitochondrial NADH generation via aldehyde dehydro- 
genase. 
3.5. Iron release from intracellular stores by hypoxia 
Hypoxia caused the intracellular release of free iron in 
hepatocytes (Fig. 3). Furthermore, NADH generating nutri- 
ents sorbitol or xylitol and ethanol increased the amount of 
iron release, whereas dihydroxyacetone decreased the 
amount of iron released under hypoxia (Fig. 3). 
Table 5 
Modulation of hypoxia induced cytotoxicity by ethanol and acetaldehyde 
Addition %Trypan blue uptake at time (min) 
60 120 180 
HYPOXIC 
None 34 + 4 52 + 6 87 + 8 * 
Ethanol (40 mM) 63+6 81+7 * 100 t 
+methyl pyrazole (0.1 mM) 35+3 48+5 63+6 
+ allopurinol (0.5 raM) 61 +5 78+7 100 
Acetaldehyde (5mM) 31 +__4 394-5 54-1-5 *
+methyl pyrazole (0.1 raM) 71 +7 89_+8 100 
AEROBIC 
None 20_+2 21_+3 23_+3 
Ethanol (40 raM) 23 _+ 3 24 _+ 3 31 _ 4 
+ methyl pyrazole (0.1 mM) 22_+2 25_+3 33_+4 
Acetaldehyde (5 mM) 25 _+ 3 29 _+ 3 37 _+ 4 
+ methyl pyrazole (0.1 mM) 235:3 26+3 29+4 
Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer 
(pH 7.4) at 37°C. Cells were maintained under hypoxic environment as 
described Section 2. Cell viability was determined as the percentage of
cells taking up Trypan blue. Values are expressed as means of the three 
separate experiments ( + S.D.). 
* Significant difference in comparison with aerobic ontrol (p < 0.001). 
, Significant difference in comparison with hypoxic ontrol (p < 0.001). 
3.6. Cytoprotection by polyphenolic antioxidants and des- 
feroxamine 
As shown in Table 6, hypoxic injury was effectively 
prevented by the polyphenolic antioxidants purpurogall in, 
caffeic acid, quercetin or ellagic acid and the superoxide 
dismutase mimic TEMPO but not by the phenolic anti- 
oxidants butylated hydroxyanisole or butylated hydroxy- 
toluene. The ferric ion chelator desferoxamine or the xan- 
thine oxidase inhibitor oxypurinol also markedly protected 
hypoxic injury, whereas hypoxanthine increased hypoxic 
cell injury. 
3. 7. Effect of  extracellular calcium on hypoxia induced cell 
injury 
As shown in Fig. 4A, hypoxic cell injury was also 
increased if extracellular calcium was increased to 5 mM. 
This Ca 2+ enhanced hypoxic cell injury was prevented by 
the addition of the Ca 2÷ chelators EGTA and DETAPAC 
(Fig. 4B). However, EGTA had little effect on hypoxic 
injury when extracellular Ca 2+ was 0.5 mM. 
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Table 6 
Prevention of hypoxia induced cytotoxicity by radical scanvengers or a 
ferric ion chelators 
Addition %Trypan blue uptake at time (min) 
60 120 180 
None 36+4 53+6 
Caffeic acid (0.3 mM) 23+3 24+4 
Purpurogallin (0.2 mM) 21 _+ 3 24 -+ 4 
Quercetin (0.1 raM) 20+3 22+4 
Ellagic acid (0.3 mM) 21 +4 23-1-3 
TEMPO (0.1 raM) 24+3 32-+4 
Ascorbate (0.3 mM) 24 + 3 29 + 4 
BHA (0.05 raM) 35+4 54+5 
BHT (0.03 mM) 34 -+ 4 56 + 6 
Desferoxamine (1 mM) 24+3 36-+4 
Hypoxanthine (5 mM) 47 _+ 4 75 _+ 7 
Oxypuranol (0.05 mM) 23 -+ 3 26 + 3 
88_+8 
35+4 * 
41+4 * 
33+4 * 
40+5 * 
43-+5 * 
37+4 * 
86+8 
84_+7 
54_+6 * 
100 
41 -+4 * 
Hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer 
(pH 7.4) at 37°C. Cells were maintained under hypoxic environment as 
described in Section 2. Cell viability was determined as the percentage of
cells taking up Trypan blue. Values are expressed as means of the three 
separate xperiments ( + S.D.). 
* Significant difference in comparison with hypoxic control (p  < 0.001). 
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Fig. 4. Extracellular calcium increased hypoxia induced cytotoxicity in 
isolated rat hepatocytes. Calcium chelators DETAPAC and EGTA de- 
layed the cytotoxicity. Key: (A) - -  (X)  no addition, (O)  1 mM Ca 2+, 
(O)  2 mM Ca 2+, and (zx) 5 mM Ca2+; (B) - -  (×)  no addition, (zx) 5 
mM Ca z+, (Q)  5 mM Ca 2++DETAPAC (1 mM), and (O)  5 mM 
Ca 2+ +EGTA (1 mM). 
4.  D iscuss ion  
Cytotoxicity caused by hypoxia is generally attributed 
to the consequences of drastic ATP depletion resulting 
because ATP utilisation outweighs ATP biosynthesis [ 19- 
21]. Recent studies have also reported that fructose pre- 
vents hepatocyte injury induced by 'chemical hypoxia' by 
enhancing the production of glycolytic ATP [22-26]. In 
the present study, we found that glycolytic substrates such 
as dihydroxyacetone or glyceraldehyde also prevented hep- 
atocyte hypoxic injury. Lactate formation was increased 
and ATP levels were not completely depleted. This would 
appear to suggest that the depletion of ATP below a 
minimal level is a critical event in the induction of irre- 
versible cell injury [27,28] and that glycolytic substrates 
are cytoprotective towards hypoxic cell injury by generat- 
ing ATP. Alternatively, acidosis resulting from fructose 
induced lactate formation has also been suggested as a 
major protecting factor in 'chemical hypoxia' [29]. How- 
ever, fructose still protected against hypoxic cell injury in 
the presence of monensin, a H+/Na + ionophore which 
equalises intracellular and extracellular pH [29] suggesting 
that acidosis was not involved in the cytoprotective mecha- 
nism. 
Other mechanisms seem to be more important for the 
maintenance of cell viability. A marked increase in the 
cellular NADH/NAD ÷ ratio occurred in hepatocytes 
maintained under hypoxic conditions. Furthermore, the 
NADH generating lycolytic nutrients such as xylitol, 
sorbitol or glycerol increased the susceptibility of hepato- 
cytes to hypoxic injury even though ATP depletion was 
partly prevented. The further increase in the cellular 
NADH/NAD ÷ ratio presumably occurs as a result of the 
action of cytosolic xylitol, sorbitol and glycerol dehydro- 
genases respectively [30-33]. Furthermore, the increase in 
hypoxic injury by xylitol and sorbitol could be eliminated 
by the addition of pyruvate to reoxidise the cytosolic 
NADH generated (data not shown). Increasing the mito- 
chondrial NADH/NAD ÷ ratio with fl-hydroxybutyrate, 
alanine and glutamine also increased the susceptibility of 
hepatocytes to hypoxic injury (Tables 2 and 3). Although 
fl-hydroxybutyrate increased the rate of ATP depletion 
(Fig. 2B), alanine and glutamine slightly prevented ATP 
depletion (Fig. 2A). Chance proposed that one of the 
factors contributing to hypoxic injury could be a reductive 
stress created by an accumulation of reducing equivalents 
[34]. The present study provides direct evidence for this 
hypothesis. Ballard also demonstrated an increase in the 
cytosolic and mitochondrial NADH/NAD + ratio in the 
livers of rats exposed to hypoxia [35]. 
The cytoprotection by fructose, dihydroxyacetone or 
glyceraldehyde could also be attributed to a restoration of 
cellular edox homeostasis a  the hypoxia induced increase 
in cellular NADH/NAD + ratio was prevented. The inter- 
mediary metabolites, oxaloacetate or acetoacetate which 
oxidise mitochondriai or cytosolic NADH [30,36] also 
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alleviated the reductive stress and prevented hypoxic cell 
injury even though ATP depletion was not affected. Cyto- 
protection by oxaloacetate or acetoacetate is therefore best 
explained in terms of affecting reductive stress rather than 
ATP depletion. The artificial electron acceptors, Methy- 
lene blue or DCPIP have previously been shown to oxidise 
cellular NADH [30,36], ancl therefore would be expected 
to counteract the reductive stress caused by hypoxia. This 
seems to be the case as hypoxic cell injury was prevented 
and ATP depletion was partially prevented and the cellular 
NADH/NAD ÷ ratio was decreased. 
A characteristic feature of alcoholic liver injury is the 
predominance of lesions in the privenular (centrilobular) 
zone of the hepatic acinus where hepatic oxygen concen- 
trations are lowest. Centrilobular necrosis was shown to 
occur in ethanol-fed rats and it was hypothesised that 
ethanol causes hypoxic injury by increasing oxygen con- 
sumption [37]. An alternative hypotheses was that ethanol 
further increased the reductive stress caused by the low 
centrilobular oxygen levels. In support of this the hepatic 
venous lactate/pyruvate ratio was markedly increased 
when ethanol was given to baboons [38]. The present study 
provides additional evidence for the latter hypothesis. Hy- 
poxic cytotoxicity in isolated hepatocytes was also in- 
creased in the presence of ethanol. Furthermore, the hepa- 
tocyte NADH/NAD ÷ ratio increased by hypoxia was 
further increased by ethanol whereas ATP depletion was 
not affected. This again suggests that reductive stress is a 
cause of hypoxic cytotoxicity. The alcohol dehydrogenase 
inhibitor, methyl pyrazole, prevented these effects of 
ethanol on hypoxic cytotoxicity suggesting that the reduc- 
tive stress was due to ethanol metabolism. A recent in vivo 
study suggested that the continuous administration of 
Methylene blue in a liquid diet to rats decreased the redox 
shift caused by ethanol and prevented ethanol induced 
hypoxic injury [39]. By contrast, acetaldehyde decreased 
the cytosolic NADH/NAD + ratio and prevented hypoxic 
cytotoxicity, an effect also prevented by inactivating alco- 
hol dehydrogenase with methyl pyrazole. 
Desferoxamine prevented hypoxic injury to perfused rat 
livers [40]. In the present study, desferoxamine prevented 
hypoxic injury. Furtherme,re, the intracellular nonbound 
iron was increased with the concomitant increase in the 
lactate/pyruvate ratio in hepatocytes under hypoxia and 
more free iron was released when the reductive stress was 
further increased with the NADH generators ethanol, sor- 
bitol, or xylitol. This suggests that reductive stress is 
responsible for intracellular iron release. Lefebvre and 
Buc-Calderon [41] suggested that hypoxia can cause iron 
release but did not give direct evidence xcept hat desfer- 
oxamine was cytoprotective in hypoxic injury. In vitro 
studies also suggest hat NADH can release Fe 2+ from 
ferritin by reducing Fe 3÷ [.42]. 
The polyphenolic antioxidants purpurogallin, caffeic 
acid, quercetin which scavenge radicals [43,44] and com- 
plex iron [45] also partly prevented hypoxic cell injury. 
This suggests that reactive oxygen species (ROS) are 
formed during hypoxia even though oxygen concentrations 
were very low. The antioxidants propylgallate and trolox C 
were also reported to protect isolated perfused rat liver 
against hypoxic injury [46,47]. Under hypoxia, the utiliza- 
tion of ATP as an energy source results in its being 
hydrolysed to ADP and then AMP. The latter then under- 
goes catabolism to hypoxanthine and xanthine which pro- 
duces ROS with the help of xanthine oxidase formed from 
xanthine dehydrogenase during hypoxia [48]. Oxypurinol 
also prevented hypoxic injury, whereas hypoxanthine in- 
creased hypoxic injury. Hypoxanthine may also act by 
increasing cytosolic NADH via xanthine dehydrogenase. 
The ROS (e.g., OH radicals) formed when free iron is 
released could modify the plasma membrane by oxidizing 
amino acids of membrane proteins to form carbonyls 
and/or oxidise tyrosine to form bityrosine intermolecular 
or intramolecular cross-links [49]. Recently, oxidative 
damage to brain protein as measured by the protein car- 
bonyl content was found to increase significantly during 
the reperfusion phase following global ischemia [50]. 
The maintenance of extracellular GSH is a critical 
component in protection against oxidative and chemically 
induced damage to receptors, transport systems and en- 
zymes in the plasma membrane. Addition of GSH in the 
media protected against oxidative injury without ransport 
into the cells and without degradation to yield cysteine. In 
the absence of added GSH, the cells release GSH to 
maintain this extracellular pool [51]. Previously, it was 
shown that cyanide and antimycin caused the efflux of 
GSH from isolated hepatocytes [52]. In the present study, 
the hypoxia induced efflux of intracellular GSH was partly 
prevented by fructose, dihyroxyacetone, but was enhanced 
by sorbitol and ethanol (data not shown). The addition of 
extracellular GSH partly prevented hypoxic injury by re- 
acting with extracellular ROS [53]. GSH depleted cells 
were highly susceptible to hypoxic injury indicating that 
intracellular GSH acts as a redox buffer to prevent hypoxic 
injury. 
Gasbarrini et al. [4] reported that in isolated rat hepato- 
cytes, anoxia increases intracellular Ca 2+ in two distinct 
phases. The first phase may involve mitochondrial Ca 2+ 
release. However, removing extracellular Ca 2+ during 
anoxia prevents both the rise in intracellular Ca 2+ and 
plasma membrane damage [4]. In the present study, hy- 
poxia induced cytotoxicity was increased with increasing 
concentrations of extracellular calcium. This suggests that 
an influx of extracellular calcium disrupts the plasma 
membrane by activating Ca2+-dependent enzymes uch as 
phospholipase A 2, proteinases, etc. [54,55]. 
On the basis of our present study, we propose the 
following sequence of events that results in hypoxic injury 
(Fig. 5). The lack of oxygen and thus mitochondrial dys- 
function inhibits NADH oxidation and results in a more 
reduced cellular redox state (NADH/NAD+). Mitochon- 
drial ATP formation is inhibited and cellular ATP levels 
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are decreased by ATP utilising cellular functions. Al- 
though the glycolytic nutrients fructose, dihydroxyacetone 
and glyceraldehyde s emed to prevent hypoxic injury by 
partly preventing ATP depletion, they also normalised the 
hepatocyte NADH/NAD ÷ ratio. Addition of the cytosolic 
NADH generating ethanol or the glycolytic substrates sor- 
bitol, xylitol, glycerol further increased the reductive stress 
caused by prolonged hypoxia and increased the release of 
intracellular iron. The mitochondrial NADH generating 
substrates /3-hydroxybutyrate, alanine or glutamine also 
increased hypoxic injury. Hypoxia may also convert xan- 
thine dehydrogenase to xanthine oxidase [47] which could 
be responsible for reactive oxygen species formation and 
cause a loss of membrane integrity. This occurred in spite 
of the partial prevention of ATP depletion by sorbitol, 
xylitol, glycerol, alanine, glutamine and the lack of an 
effect of ethanol on ATP depletion, By contrast, he NADH 
oxidising intermediary metabolites, oxaloacetate or ace- 
toacetate, acetaldehyde or artificial electron acceptors pre- 
vented hypoxic injury and normalised the hepatocyte 
NADH/NAD ÷ ratio. ATP depletion was, however, not 
affected by oxaloacetate, acetoacetate and was partly pre- 
vented by acetaldehyde. The cell's susceptibility to hy- 
poxic injury may therefore depend less on the cell's capac- 
ity to maintain energy status and more on the cell's 
capacity to maintain redox homeostasis. 
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